chevron_leftBack
As of 24 April 2025, Dr. Lal PathLabs Ltd. has a market cap of $2.7B USD, ranking #4415 globally and #301 in India. It ranks #390 in the Healthcare sector, and #32 in the Diagnostics & Research industry.
Key Stats
Market Cap
$2.7BUSD
230.16B INR
Enterprise Value
$2.59BUSD
221.21B INR
Revenue (TTM)
$281.76MUSD
24.04B INR
EBITDA (TTM)
$73.59MUSD
6.29B INR
Net Income (TTM)
$48.85MUSD
4.17B INR
EBITDA Margin
26%
Profit Margin
17%
PE Ratio
55.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Shankha Banerjee
open_in_new
Employees
4,099
Founded
1949
Website
lalpathlabs.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.2% | 2.2% | 9% | -1.2% | -16% | 25% |
Upcoming Earnings
Earnings Date
Fri, May 9
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
LALPATHLAB
Dr. Lal PathLabs Ltd
ISIN: INE600L01024
Shares Out.:
Shares Outstanding:
83.327M1
Shares Float:
37.245M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.77K INR | |
|
539524
(LALPATHLAB)
Dr. Lal PathLabs Ltd
ISIN: INE600L01024
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.76K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Dr. Lal PathLabs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.
